AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...
Since 2011, immunotherapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Every person who hears the words “you have cancer” has a unique story. As part of Cancer Today’s mission...
When I started my postdoc at Georgetown University’s Lombardi Comprehensive Cancer Center in May 2016, I was thrilled to...
Decades of research have led to the identification of an increasing number of cancer-causing substances in our environment. These...
Back for the month of June are the editors’ picks from the eight scientific journals published by the American...